Jul 26, 2022, 09:30 by

Global clinical trial kits market was valued at USD 1.42 billion in 2021 and is estimated to reach USD 2.85 Billion by 2030, growing at a CAGR of 8.3% during the forecast period.

Jul 26, 2022, 09:30 by

Creative Biogene offers full-process services of eukaryotic microbial 18S sequencing from DNA extraction to PCR amplification, purification, sequencing, and analysis.

Jul 25, 2022, 10:28 by

Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics.

Jul 25, 2022, 10:27 by

Partnership delivers advanced approaches for bringing neurodegenerative disease treatments to market

Jul 25, 2022, 10:27 by

Jul 25, 2022, 10:27 by

Jul 25, 2022, 10:27 by

Durham, NC, July 21, 2022 – BioAgilytix Labs, LLC (BioAgilytix) has secured a valuable seal of approval for the safety of its IT systems and processes.

Jul 22, 2022, 09:23 by

What are the key features an eClinical software should have? This list will guide you through the selection process of your next eClinical Platform

Jul 21, 2022, 09:11 by

Jul 21, 2022, 09:11 by

Pharmaceutical temperature-controlled specialist Tower Cold Chain has secured £6.75million in investment, to reinforce the business as the leader in robust, reliable, and reusable cold chain solutions, following a period of rapid and sustained growth.

Jul 21, 2022, 09:10 by

Creative Diagnostics announced the launch of several Monkeypox Virus Antibodies and Antigens for the detection of Monkeypox viruses.

Jul 21, 2022, 09:10 by

STEMart introduced new Antibiotic Potency Tests to assess the bioactivity or potency of various antibiotics for medical devices.

Jul 21, 2022, 09:10 by

Amerigo Scientific announced the release of a new Anex® Brush that allowed optimal sampling the entire anal canal including the anal transformation zone.

Jul 21, 2022, 01:00 by User Not Found

Clinical Research News | A clinical team at Dana Farber Cancer Institute and Mount Sinai explored oncology clinical trial disruption during the COVID-19 pandemic. They found that substantial disruptions early in the pandemic gradually recovered, but some lasting changes remain.

Jul 20, 2022, 09:08 by

AARDEX® Group and BIOCORP Recruited by Trials@Home - Decentralized Clinical Trial Centre of Excellence Combining BIOCORP’s pen injector add-on with AARDEX® Group’s Software to improve adherence to medication in a Hybrid Phase IV Diabetes Study.

Jul 20, 2022, 09:08 by

uMotif expands leadership team to support growth in US and EU markets LONDON and BOSTON, 19 July 2022 -- uMotif, creators of the patient-first eCOA / ePRO and engagement platform transforming the reliability of patient-reported and site-based endpoint data has appointed three new executive leaders. The expanded leadership team will drive uMotif’s ambitious growth strategy in the US and European markets, including guiding future development and adoption of uMotif’s intuitive, retention-boosting technology.

Jul 20, 2022, 09:07 by

CD Genomics MicrobioSeq has launched the Bacterial Whole Genome De Novo Sequencing to help scientific researchers better understand bacterial biodiversity, physiology, metabolism and function.

Jul 20, 2022, 09:07 by

Chloroplast DNA (cpDNA) plays an important role in revealing the origin of species, biological evolution, and kinship between different species. CD Genomics is pleased to offer the Chloroplast DNA (cpDNA) Sequencing service that has important applications in evolutionary biology research and forensic science.

Jul 19, 2022, 09:37 by

Celegence acquires Qdossier to extend network of regulatory affairs services consultants and solutions for the pharmaceutical industry

Jul 19, 2022, 01:00 by User Not Found

Clinical Research News | In collaboration with physicians from around the world, researchers at the University of Pittsburgh and the University of California San Diego School of Medicine recently reported on a series of 20 consecutive cases where an intractable, non-tuberculous Mycobacterium infection was treated with phage therapy over an average course of six months. More than half of those patients saw a favorable clinical or microbiological outcome.